HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Featured

New Book Release by RJG Arnold: Pharmacoeconomics: From Theory to Practice

An understanding of the basic principles of pharmacoeconomics is essential if stakeholders in the healthcare arena hope to meet the burgeoning challenges posed by shrinking budgets, healthcare rationing, medication shortages, and an aging global population. The 2nd edition of Pharmacoeconomics: From […]

more info 01/14/2021View Related Articles
Bookmark and Share

New Data Show Retail Medicine Prices Fell in 2019

In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & Medicaid Services (CMS) published recently in Health Affairs. While retail prescription medicine spending grew 5.7% that same year, this […]

more info 01/14/2021View Related Articles
Bookmark and Share

Pandemic Propels Health Systems to Mull Acquisitions, Partnerships

Nearly a year after the first confirmed case of COVID-19 in the U.S., some of the nation's largest health systems made a case for the need to accelerate toward value-based arrangements and potentially acquiring or partnering with health plans to become an integrated system. Amid new records for […]

more info 01/14/2021View Related Articles
Bookmark and Share

Gaps in Health Data are Barrier to Health Equity

COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to whites. Similarly, the rate of COVID-19 related deaths among Black Americans and American Indian/Alaskan […]

more info 01/14/2021View Related Articles
Bookmark and Share

Cerner Aspires to Build $1B Data Business in Pharma Market

Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building a $1 billion data business for the healthcare and life sciences industries. Cerner announced plans in December to acquire the health division of Kantar Group, which […]

more info 01/14/2021View Related Articles
Bookmark and Share

[Podcast] Creating an HEOR Function Within Medical Affairs

In this episode of the MAPS Elevate podcast series, we explore Health Economics and Outcomes Research (HEOR), looking at why a Medical Affairs organization needs an HEOR function and how to build this capability within Medical Affairs. This podcast is brought to you by AlphaGroup an independent […]

more info 01/13/2021View Related Articles
Bookmark and Share

Implications of Price Transparency for Providers and Patients as New Rules Go into Effect

A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common […]

more info 01/13/2021View Related Articles
Bookmark and Share

STaRT-RWE: Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies

In alignment with the International Council of Harmonization’s strategic goals, a public-private consortium has developed a structured template for planning and reporting on the implementation of real world evidence (RWE) studies of the safety and effectiveness of treatments. The template serves as […]

more info 01/13/2021View Related Articles
Bookmark and Share

Disparities in the Wage‑and‑Salary Earnings of HEOR Professionals

Using self-reported survey data collected in 2017 from a subset of HE/OR/MA professionals in the HealthEconomics.com global subscriber list, researchers performed a study aiming to estimate the wage-and-salary earnings of a sample of health economics, outcomes research, and market access (HE/OR/MA) […]

more info 01/13/2021View Related Articles
Bookmark and Share

2021 ARM – Call for Abstracts

Present your work at the premier forum for health services researchers, policy analysts, clinicians and community leaders using evidence and data to improve health and health care for all. The 2021 Annual Research Meeting is organized around 21 themes and five submission types. All individual […]

more info 01/13/2021View Related Articles
Bookmark and Share

Specialty Generics Face Perverse Incentives In Medicare Part D

Whether specialty generics are cheaper to payers than their originator branded counterparts is partly a function of the level of rebates drugmakers are willing to offer to a pharmacy benefit manager (PBM) to secure preferred placement on the formulary. Originator firms can outmaneuver specialty […]

more info 01/12/2021View Related Articles
Bookmark and Share

Guest Blog Posts for the Journal of HEOR Website

The Journal of Health Economics and Outcomes Research is currently in the process of soliciting guest blog posts for the JHEOR web site and wanted to invite you to participate in this opportunity. We're seeking submissions on a range of topics related to HEOR and, in particular, right now, posts […]

more info 01/12/2021View Related Articles
Bookmark and Share

Race Rarely at Top of Patient’s Medical Record

Even though differences in health outcomes between Black and white people are well-established, a small survey finds that patients' race is not routinely mentioned atop their electronic medical record. The survey looked at data from 1,200 patients, and checked for race in the first line of the EMR […]

more info 01/12/2021View Related Articles
Bookmark and Share

Drugmakers Raise Prices 3.3% in the New Year

This month pharmaceutical companies have increased list prices on hundreds of branded drugs -- mostly between 2-7% (with only a couple companies daring the optics of double-digit hikes). In aggregate, however, the rate of increase across a market basket of the most common branded therapies was lower […]

more info 01/12/2021View Related Articles
Bookmark and Share

ICER Identifies Most Significant 2019 US Drug-Price Hikes

ICER Logo

The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription drugs in the United States. Among the top drugs with price increases in 2019 that had substantial effects on US spending, ICER determined that seven of 10 […]

more info 01/12/2021View Related Articles
Bookmark and Share

EQRx Scales Disruptive Model of Important New Medicines

EQRx, a company committed to developing and delivering important new medicines at lower prices, today announced that it has raised $500 million in Series B financing. Since launching a year ago, EQRx has raised approximately $750 million to advance its mission of bringing new medicines to treat […]

more info 01/11/2021View Related Articles
Bookmark and Share

[On-demand Webinar] Avalere 2021 Healthcare Industry Outlook

The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, […]

more info 01/11/2021View Related Articles
Bookmark and Share

Fishawack Health Acquires The Hive Health Group

Fishawack Health (Fishawack) is a leading global commercialization partner for the modern life sciences era. The company’s three core operating units—Commercial, Consulting, and Medical Communications—can be leveraged individually but are designed for dynamic collaboration, with expert teams […]

more info 01/11/2021View Related Articles
Bookmark and Share

Virtual ISPOR 2021 Abstracts Due & Reviewers Needed!

Virtual ISPOR 2021 offers you an opportunity to present your research virtually to the leading global conference for health economics and outcomes research. Submit today and contribute to the future of HEOR and the difference it is making in today’s global healthcare landscape. New This Year: […]

more info 01/11/2021View Related Articles
Bookmark and Share

The 5 Numbers That Will Define Healthcare Value in 2021

Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. One systematic review (in preprint) has already reported on 81 such studies. In these studies, which […]

more info 01/11/2021View Related Articles
Bookmark and Share

Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets

Unlike private health insurance, Medicare Part D drug plans have no cap on patients’ 5% coinsurance costs once they hit $6,550 in drug spending this year (up from $6,350 in 2020), except for very low-income beneficiaries. President-elect Biden favors a cap, and Democrats and Republicans in Congress […]

more info 01/08/2021View Related Articles
Bookmark and Share

Read Up On How Regulators Are Using RWE

RWE is playing a growing role in FDA approvals. According to an Aetion analysis, 49 percent of submissions for new drugs and biologics in 2019 included an RWE study. In 2020, that figure jumped to 75 percent. In Aetion’s growing library of FDA Decision Alerts, they share examples in which RWE was […]

more info 01/08/2021View Related Articles
Bookmark and Share

The Bane of Prior Authorization

In a STAT op-ed, Brian Barnett, a psychiatrist at the Cleveland Clinic, discusses the burden of completing prior authorizations to ensure patients can retain access to medications. While prior authorizations can be used to ethically and efficiently steer patients toward lower-cost, clinically […]

more info 01/08/2021View Related Articles
Bookmark and Share

Has COVID-19 Changed Prescription Drug Pricing Forever?

As the COVID-19 pandemic continues to disrupt our lives and health care system on a historic scale, it is worth considering whether it has also revolutionized drug development and pricing in a profound way. COVID-19 vaccines were produced in record time using a novel approach: Drug makers committed […]

more info 01/08/2021View Related Articles
Bookmark and Share

ICER To Release Final Assessment of Selected High-impact Drugs

ICER will be reviewing changes in the evidence base for each of these drugs and assess whether or not new clinical data exists that could suggest that the drugs could be significantly more beneficial for patients than what was previously understood. ICER published the final draft of its first UPI […]

more info 01/08/2021View Related Articles
Bookmark and Share

Enjoy AMCP Learn Programs Available to You

AMCP Learn provides numerous on-demand CPE programs that will help you with your goals. Enjoy programs like Navigating Changes in Clostridioides difficile Prevention and Treatment, Value-based Contracting, Fundamentals of Managed Care Pharmacy Certificate Programs, and more! […]

more info 01/07/2021View Related Articles
Bookmark and Share

Volunteer with AMCP Foundation

nurseWpatient

Give the gift of time by volunteering. The AMCP Foundation has opportunities for you to donate your time. Volunteering is a great way to be hands-on as you help fulfill our mission of research and education. Become a volunteer today! AMCP Foundation P&T Competition Judges(Apply by Jan. 17, […]

more info 01/07/2021View Related Articles
Bookmark and Share

The AMCP Podcast Powered by PopHealth Week Launches Next Week

AMCP is proud to partner with renowned health care experts Fred Goldstein and Gregg Masters from PopHealth Week to launch a podcast that fosters conversation about the biggest challenges facing managed care pharmacy and up-to-the minute hot topics.  They are shining the spotlight on leading voices […]

more info 01/07/2021View Related Articles
Bookmark and Share

Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics

Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to facilitate the analysis of real-world data. EMA will use IHD to undertake rapid analyses of Electronic Healthcare Data (EHDs) […]

more info 01/06/2021View Related Articles
Bookmark and Share

Tracing the Health Care Experience Informs Decision-making

Mapping the patient journey is a worthwhile exercise to undertake because it answers critical questions of interest to all health care stakeholders. The richness of patient journey mapping can help develop patient cohorts and assess effectiveness of therapeutics. Total health care utilization and […]

more info 01/06/2021View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 116
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Data removes the barriers to understanding rare disease
  • The Future Was Today
  • How Can a Supply Chain Dashboard Yield Greater Clinical Trial Insights, Cost Control, and Efficiency?
  • Strategies for Engaging Vulnerable Populations in Healthcare
  • Tracing the health care experience informs decision-making
  • Driving More Value and Cost Savings With SDOH Data
  • Advancing Early Stage Oncology Research with Adaptive Designs and Master Protocols
  • Transformation of Clinical Trial Design and Operations
  • Using real-world data to close the rare disease data gap
  • Analysis and Insights from Real-World Clinical Registries: RA, GCA, JIA, & SLE
  • The role of real-world evidence in FDA approvals
  • Cytel Scientists Call for a “Statistician-First Workflow” to Optimize Drug Development
  • Specialty Pharmacy Virtual Technology Adoption on the Rise
  • Clinical Trials Have Changed. Has Your Tech Strategy?
  • Beyond COVID-19: Life sciences reimagined
  • How Real-World Evidence Can Support Adoption of New Technology
  • Interventional Studies
  • Virtual Expanded Access Program Providing Breast Cancer Patients Early Access to Treatment During the COVID-19 Pandemic
  • Pediatric Drug Development: Trends and Perspectives in the United States
  • Can Clinical Studies Go Virtual?
  • ICER’s impact on payer decision making
  • Representation and Diversity in Clinical Trials
  • Advisory Boards: The Good, The Bad, and The Ugly
  • An Initial Framework to Describe and Classify Integrated Scientific Advice Procedures
  • Ensuring timely dissemination of research: a guide to working as a medical publications professional
  • Patient Intelligence and Insights Reports
  • Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines
  • Patient Centricity
       Exploring the patient dynamic from different perspectives
  • How to Excel at Next Generation Trial Execution
  • Payers: The New Catalysts of Better Health

Syndicated Reports

  • Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19
  • Health Economics & Outcomes Research (HEOR) Services Market to 2027
  • Healthcare Artificial Intelligence Market by Product and Services – Global Forecast to 2027
  • Bioinformatics Market – Growth, Share, Opportunities & Competitive Analysis, 2020 – 2028
  • Big Data and AI in Market Access
  • Altruista Health Payer Index Survey 2020 Report
  • Innovations in Drug Pricing and Reimbursement 2020
  • Healthcare Reimbursement Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026
  • Real World Data for Orphan Drugs: Meeting the Data Analysis Challenge
  • Directory of Health Plans: Trusted Health Insurance Plan Enrollment and Affiliation Data
  • Global Value-Based Reimbursement Software Market Report
  • Health Economics & Outcomes Research (HEOR) Services Market: Emerging industries, Challenges and Threats Faced by Key Vendors(Axtria, Avalon Health Economics, Cardinal Health, ICON, IQVIA, McKesson, MEDLIOR, Optum, PharmaLex, (PPD), RTI)
  • World Preview 2019, Outlook to 2024
  • Provider Perceptions of Value-Based Care
  • Healthcare Industry’s Response to COVID-19
  • Value-Based Care Assessment
  • Pharmacy Benefit Management Market in US – Industry Outlook and Forecast 2020-2025
  • 2025 Growth: Healthcare Reimbursement Market set to grow with massive rate by 2020 to 2025
  • Global Specialty Pharmaceutical Market 2020- Pfizer, Roche, Amgen, AbbVie
  • 3 Trends to Accelerate Time to Market
  • Scientific Research And Development Services Global Market Report 2020-30: Covid 19 Impact and Recovery
  • Engaging with ICER: Lessons and insights for pharma
  • COVID-19 Implications for pharma: US payer insights
  • Pricing and Reimbursement in Oncology
  • Digital Technologies: New Strategies for Customer Engagement
  • Real World Evidence (RWE) Solutions Market by Component, Application, End User – Global Forecast to 2024
  • 2019 Healthcare Benchmarks: Social Determinants of Health
  • Pricing Transparency in Pharma
  • Medical Affairs: The Roadmap to 2025
  • Health Economics & Outcomes Research (HEOR) Services Market Share & Forecast, 2020–2026
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute